Patrizia Tempora

Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment

F. Locatelli, D. Fruci, V. Lucarini, 2021, Cancers.

ERAP1 and ERAP2 Enzymes: A Protective Shield for RAS against COVID-19?

D. Fruci, S. Gaspari, M. Algeri, 2021, International journal of molecular sciences.

Targeting the antigen processing and presentation pathway to overcome resistance to immune checkpoint therapy

D. Fruci, L. Cifaldi, V. Lucarini, 2022, Frontiers in Immunology.

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function

P. Romania, D. Fruci, L. Cifaldi, 2021, Frontiers in Immunology.

Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma

L. Di Marcotullio, M. Cilli, M. Scarsella, 2022, Journal of Experimental & Clinical Cancer Research.

Impact of Natural Occurring ERAP1 Single Nucleotide Polymorphisms within miRNA-Binding Sites on HCMV Infection

D. Fruci, V. Lucarini, O. Melaiu, 2020, International journal of molecular sciences.